Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 1 - 10 of 21 results
-
Elimination of senescent cells with senolytic host-directed therapy reduces tuberculosis progression in susceptible mice models
Date:
10/01/2026Topics:
Lead Investigators:
-
Center for accelerated development of drug candidates targeting high threat bacterial infections
Date:
03/01/2025Lead Investigators:
-
Efficacy of novel 4-drug combinations in the relapsing BALB/c mouse model of TB (GMRI-0007)
Date:
09/01/2024Topics:
Lead Investigators:
-
Targeting CCRL2 as an adjunctive therapeutic strategy in tuberculosis
Date:
07/01/2024Topics:
Lead Investigators:
-
TB Alliance Combo Study
Date:
01/01/2024Topics:
Lead Investigators:
-
Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium
Date:
12/02/2023Topics:
Lead Investigators:
-
Pretargeting Bacterial Therapy of HER2+ Breast Cancer
Date:
06/01/2023Topics:
Lead Investigators:
-
Assess the activity of MRX-V against M. abscessus
Date:
03/01/2023Lead Investigators:
-
Characterizing CaeA-mediated rifampin tolerance in MTB
Date:
11/10/2022Topics:
Lead Investigators:
-
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus
Date:
08/16/2022Topics:
Lead Investigators: